• Focus:
  • For Inquires Call:
    800.320.6497 ext. 201-5390
  • Contact:
    Ellen Olson
  • Expertise:
    Budget Impact
    Emerging Markets
    Health Policy, Reform, Delivery
    HEOR General
    LatePhase Research
    Market Access
    Patient-Reported Outcomes
Listing Overview

Xcenda’s global health economics and outcomes research consultants advise manufacturers on the most effective methodologies to generate health economic evidence that payers will find credible, including data that will demonstrate a product’s impact on the total cost of care. We help our manufacturer clients develop strategies to create and communicate a credible and effective product value story to payers, in the US and within specific countries throughout the world. When it comes to specialty pharmaceuticals, particularly in oncology and orphan/rare disease, no one understands the science of value better than Xcenda.

Two decades of experience and our commitment to applied health outcomes means we translate your product’s scientific evidence into strategies and tools that make an impact in the real world. Engage Xcenda for applied health outcomes expertise via traditional consulting arrangements or flexible contract staffing.

Global companies and pre-commercialization firms turn to Xcenda to:
• Develop early-stage HEOR and market access strategies
• Understand the approval and decision-making processes related to coverage, reimbursement, and pricing in both established and emerging markets
• Build the tactical tools and training materials to communicate the product value story at launch
• Uncover new real-world evidence to demonstrate comparative effectiveness and extend a product’s commercial opportunities later in the life cycle

No video attached.
Write Review
There are no reviews posted yet.